OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
46
Results
Show all
Save search
Copy query
Show results for
Unknown
(46)
Publication Date
Release Date
2021
(11)
2023
(8)
2022
(7)
2024
(5)
2016
(4)
2020
(3)
2025
(2)
2019
(1)
2018
(1)
2017
(1)
2015
(1)
2012
(1)
2011
(1)
Previous
page
1 / 5
You're on page
1
page
2
page
3
page
4
page
5
Next
page
Sort
by:
Relevance
Page size
10
A Recurrent Mosaic Mutation in SMO, Encoding the Hedgehog Signal Transducer Smoothened, Is the Major Cause of Curry-Jones Syndrome.
Not available
S-EPMC4908219
|
biostudies-literature
Cite
Intravenous Vitamin C for Patients Hospitalized With COVID-19: Two Harmonized Randomized Clinical Trials.
Not available
S-EPMC10600726
|
biostudies-literature
Cite
Prostate Cancer Susceptibility in Men of African Ancestry at 8q24.
Not available
S-EPMC4948565
|
biostudies-literature
Cite
Global Impact of the COVID-19 Pandemic on Cerebral Venous Thrombosis and Mortality.
Not available
S-EPMC9194544
|
biostudies-literature
Cite
The predictive ability of the 313 variant-based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant.
Not available
S-EPMC8460445
|
biostudies-literature
Cite
Crowdsourcing biocuration: The Community Assessment of Community Annotation with Ontologies (CACAO).
Not available
S-EPMC8553046
|
biostudies-literature
Cite
Comprehensive Rare Variant Analysis via Whole-Genome Sequencing to Determine the Molecular Pathology of Inherited Retinal Disease.
Not available
S-EPMC5223092
|
biostudies-literature
Cite
Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers.
Not available
S-EPMC6880781
|
biostudies-literature
Cite
Rare and functional SIAE variants are not associated with autoimmune disease risk in up to 66,924 individuals of European ancestry.
Not available
S-EPMC3287292
|
biostudies-literature
Cite
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8084355
|
biostudies-literature
Cite
Previous
page
1 / 5
You're on page
1
page
2
page
3
page
4
page
5
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets